Sriram Ryali

Chief Financial Officer, Eiger BioPharmaceuticals, Inc.

Companies

Caribou Biosciences, Inc.Chief financial officer Jan 10, 2025 to now¹
CodexisChief financial officer Jan 25, 2023 to Jan 2, 2024²
Eiger BioPharmaceuticals, Inc.Chief financial officer Dec 27, 2018 to Mar 14, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Codexis CDXS175,791 shares⁴$218.0K at $1.24Jan 1, 2024
Caribou Biosciences, Inc. CRBU72,360 shares⁵$34.0K at $0.47Feb 20, 2026
Eiger BioPharmaceuticals, Inc.41,566 shares⁶Mar 14, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 20, 2026Granted 55,000 shares of Caribou Biosciences, Inc.⁵
Jan 29, 2025Bought 17,360 shares at $1.42 of Caribou Biosciences, Inc.⁷
Jan 1, 2024Granted 52,350 shares of Codexis⁴
Sep 8, 2023Bought 11,650 shares at $1.70 of Codexis⁸
Feb 10, 2023Granted 111,791 shares of Codexis⁹
Mar 14, 2022Sold 2,266 shares at $5.60 of Eiger BioPharmaceuticals, Inc.⁶
Mar 11, 2022Granted 24,000 shares of Eiger BioPharmaceuticals, Inc.¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCaribou Biosciences, Inc., Chief financial officer
2
SEC EDGARCodexis, Chief financial officer
3
SEC EDGAREiger BioPharmaceuticals, Inc., Chief financial officer
4
SEC EDGARCodexis shares after the filing of Jan 1, 2024
5
SEC EDGARCaribou Biosciences, Inc. shares after the filing of Feb 20, 2026
6
SEC EDGAREiger BioPharmaceuticals, Inc. shares after the filing of Mar 14, 2022
7
SEC EDGARForm 4 filed Jan 30, 2025
8
SEC EDGARForm 4 filed Sep 12, 2023
9
SEC EDGARForm 4 filed Feb 14, 2023
10
SEC EDGARForm 4 filed Mar 11, 2022